Total Raised

$43.25M

Investors Count

6

Deal Terms

1

Funding, Valuation & Revenue

4 Fundings

Quartet Medicine has raised $43.25M over 4 rounds.

Quartet Medicine's latest funding round was a Dead for on November 18, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/18/2017

Dead

Dead

$XXM

0

FY undefined

1

1/6/2016

Corporate Minority

$XXM

$XXM

0

FY undefined

10

10/7/2015

Series A - II

$XXM

$XXM

0

FY undefined

10

10/23/2014

Series A

$XXM

$XXM

0

FY undefined

10

Date

11/18/2017

1/6/2016

10/7/2015

10/23/2014

Round

Dead

Corporate Minority

Series A - II

Series A

Amount

$XXM

$XXM

$XXM

Investors

Dead

Valuation

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

Start free trial
New call-to-action

Quartet Medicine Deal Terms

1 Deal Term

Quartet Medicine's deal structure is available for 1 funding round, including their Series A from October 23, 2014.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

Quartet Medicine Investors

6 Investors

Quartet Medicine has 6 investors. Merck invested in Quartet Medicine's Corporate Minority funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/6/2016

1/6/2016

1
Corporate Minority

Corporation

New Jersey

00/00/0000

00/00/0000

Remeditex Ventures

Subscribe to see more

Venture Capital

Texas

00/00/0000

00/00/0000

Atlas Venture

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Novartis Venture Funds

Subscribe to see more

Corporate Venture

Switzerland

00/00/0000

00/00/0000

Partners Innovation Fund

Subscribe to see more

Venture Capital

Massachusetts

First funding

1/6/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/6/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Remeditex Ventures

Atlas Venture

Novartis Venture Funds

Partners Innovation Fund

Rounds

1
Corporate Minority

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Corporate Venture

Venture Capital

Location

New Jersey

Texas

Massachusetts

Switzerland

Massachusetts

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.